Rapamycin suppresses postnatal muscle hypertrophy induced by myostatin-inhibition accompanied by transcriptional suppression of the Akt/mTOR pathway

Myostatin (MSTN) is a well-known negative growth factor of muscle mass, and studies have shown that MSTN-inhibition would be a potential strategy to treat muscle atrophy seen in various clinical conditions. Recent studies suggest that MSTN-inhibition induces skeletal muscle hypertrophy through up-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Dong hyuck, Yang, Jinzeng, Kim, Yong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362869/
https://www.ncbi.nlm.nih.gov/pubmed/30805561
http://dx.doi.org/10.1016/j.bbrep.2018.12.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362869/
https://www.ncbi.nlm.nih.gov/pubmed/30805561
http://dx.doi.org/10.1016/j.bbrep.2018.12.009

Ejemplares similares